title: Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
authors.affiliation: ESC Task Force on Antiplatelets, University of Rome La Sapienza, II Facoltà di Medicina e Chirurgia, Via di Grottarossa, 1035, 00189 Roma, Italy. cpattrono@unich.it
authors.forename: Carlo
authors.initials: C
authors.lastname: Patrono
authors.forename: Fedor
authors.initials: F
authors.lastname: Bachmann
authors.forename: Colin
authors.initials: C
authors.lastname: Baigent
authors.forename: Christopher
authors.initials: C
authors.lastname: Bode
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caterina
authors.forename: Bernard
authors.initials: B
authors.lastname: Charbonnier
authors.forename: Desmond
authors.initials: D
authors.lastname: Fitzgerald
authors.forename: Jack
authors.initials: J
authors.lastname: Hirsh
authors.forename: Steen
authors.initials: S
authors.lastname: Husted
authors.forename: Jan
authors.initials: J
authors.lastname: Kvasnicka
authors.forename: Gilles
authors.initials: G
authors.lastname: Montalescot
authors.forename: Luis Alberto
authors.initials: LA
authors.lastname: García Rodríguez
authors.forename: Freek
authors.initials: F
authors.lastname: Verheugt
authors.forename: Jozef
authors.initials: J
authors.lastname: Vermylen
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Silvia G
authors.initials: SG
authors.lastname: Priori
authors.forename: Maria Angeles
authors.initials: MA
authors.lastname: Alonso Garcia
authors.forename: Jean Jacques
authors.initials: JJ
authors.lastname: Blanc
authors.forename: Andrzej
authors.initials: A
authors.lastname: Budaj
authors.forename: Martin
authors.initials: M
authors.lastname: Cowie
authors.forename: Veronica
authors.initials: V
authors.lastname: Dean
authors.forename: Jaap
authors.initials: J
authors.lastname: Deckers
authors.forename: Enrique
authors.initials: E
authors.lastname: Fernández Burgos
authors.forename: John
authors.initials: J
authors.lastname: Lekakis
authors.forename: Bertil
authors.initials: B
authors.lastname: Lindahl
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Mazzotta
authors.forename: João
authors.initials: J
authors.lastname: Morais
authors.forename: Ali
authors.initials: A
authors.lastname: Oto
authors.forename: Otto A
authors.initials: OA
authors.lastname: Smiseth
authors.forename: João
authors.initials: J
authors.lastname: Morais
authors.forename: Jaap
authors.initials: J
authors.lastname: Deckers
authors.forename: Rafael
authors.initials: R
authors.lastname: Ferreira
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Mazzotta
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Frederico
authors.initials: F
authors.lastname: Teixeira
authors.forename: Robert
authors.initials: R
authors.lastname: Wilcox
mesh_terms: D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy*; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors